Literature DB >> 33634117

Xanthine Oxidoreductase Is Involved in Chondrocyte Mineralization and Expressed in Osteoarthritic Damaged Cartilage.

Sonia Nasi1, Mariela Castelblanco1, Véronique Chobaz1, Driss Ehirchiou1, Alexander So1, Ilaria Bernabei1, Teruo Kusano2, Takeshi Nishino2, Ken Okamoto2, Nathalie Busso1.   

Abstract

Pathologic calcification of cartilage consists of the formation of basic calcium phosphate (BCP) and/or calcium pyrophosphate dihydrate (CPPD) containing calcium crystals in mature hyaline or articular cartilage and is associated with aging, cartilage injury and likely plays a role in accelerating the pathology of osteoarthritis (OA). The pathways regulating joint calcification, in particular cartilage calcification, are not completely understood, but inflammation and the formation of reactive oxygen species (ROS) are contributory factors. The xanthine oxidase (XO) form of xanthine oxidoreductase (XOR), the key enzyme in xanthine and uric acid metabolism, is a major cellular source of superoxide. We hypothesized that XOR could be implicated in chondrocyte mineralization and cartilage calcification and degradation in OA. We showed both in murine primary chondrocyte and chondrogenic ATDC5 cells, that mineralization was inhibited by two different XOR inhibitors, febuxostat and allopurinol. In addition, XOR inhibition reduced the expression of the pro-mineralizing cytokine interleukin-6 (IL-6). We next generated XOR knock-out chondrocyte cell lines with undetectable XOR expression and XO activity. XOR knock-out chondrocyte cells showed decreased mineralization and reduced alkaline phosphatase (Alp) activity. To assess the precise form of XOR involved, primary chondrocytes of XOR mutant mice expressing either the XDH form (XDH ki) or the XO form (XO ki) were studied. We found that XO ki chondrocytes exhibited increased mineralization compared to XDH ki chondrocytes, and this was associated with enhanced Alp activity, ROS generation and IL-6 secretion. Finally, we found increased XOR expression in damaged vs. undamaged cartilage obtained from OA patients and XOR expression partially co-localized with areas showing pathologic calcification. Altogether, our results suggest that XOR, via its XO form, contribute to chondrocyte mineralization and pathological calcification in OA cartilage.
Copyright © 2021 Nasi, Castelblanco, Chobaz, Ehirchiou, So, Bernabei, Kusano, Nishino, Okamoto and Busso.

Entities:  

Keywords:  animal model; calcium-containing crystals; chondrocyte calcification; osteoarthritis; xanthine oxidoreductase

Year:  2021        PMID: 33634117      PMCID: PMC7900416          DOI: 10.3389/fcell.2021.612440

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  37 in total

1.  Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.

Authors:  Zulipiya Aibibula; Maierhaba Ailixiding; Munetaka Iwata; Jinying Piao; Yasushi Hara; Atsushi Okawa; Yoshinori Asou
Journal:  Biochem Biophys Res Commun       Date:  2016-02-20       Impact factor: 3.575

Review 2.  Calcium crystal deposition diseases - beyond gout.

Authors:  Geraldine M McCarthy; Aisling Dunne
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

3.  The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.

Authors:  Shunsuke Yamada; Masatomo Taniguchi; Masanori Tokumoto; Jiro Toyonaga; Kiichiro Fujisaki; Takaichi Suehiro; Hideko Noguchi; Mitsuo Iida; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

4.  Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients With Medial Knee Osteoarthritis.

Authors:  Svetlana Krasnokutsky; Charles Oshinsky; Mukundan Attur; Sisi Ma; Hua Zhou; Fangfei Zheng; Meng Chen; Jyoti Patel; Jonathan Samuels; Virginia C Pike; Ravinder Regatte; Jenny Bencardino; Leon Rybak; Steven Abramson; Michael H Pillinger
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

Review 5.  Urate and osteoarthritis: Evidence for a reciprocal relationship.

Authors:  Tuhina Neogi; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Joint Bone Spine       Date:  2018-11-22       Impact factor: 4.929

6.  Calcification of articular cartilage in human osteoarthritis.

Authors:  M Fuerst; J Bertrand; L Lammers; R Dreier; F Echtermeyer; Y Nitschke; F Rutsch; F K W Schäfer; O Niggemeyer; J Steinhagen; C H Lohmann; T Pap; W Rüther
Journal:  Arthritis Rheum       Date:  2009-09

7.  Pathological calcification in osteoarthritis: an outcome or a disease initiator?

Authors:  Jian-Fei Yan; Wen-Pin Qin; Bo-Cheng Xiao; Qian-Qian Wan; Franklin R Tay; Li-Na Niu; Kai Jiao
Journal:  Biol Rev Camb Philos Soc       Date:  2020-03-24

8.  Chondrogenic ATDC5 cells: an optimised model for rapid and physiological matrix mineralisation.

Authors:  P T Newton; K A Staines; L Spevak; A L Boskey; C C Teixeira; V E Macrae; A E Canfield; C Farquharson
Journal:  Int J Mol Med       Date:  2012-08-31       Impact factor: 4.101

9.  Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification.

Authors:  Kozo Morita; Takeshi Miyamoto; Nobuyuki Fujita; Yoshiaki Kubota; Keisuke Ito; Keiyo Takubo; Kana Miyamoto; Ken Ninomiya; Toru Suzuki; Ryotaro Iwasaki; Mitsuru Yagi; Hironari Takaishi; Yoshiaki Toyama; Toshio Suda
Journal:  J Exp Med       Date:  2007-06-18       Impact factor: 14.307

10.  The protective role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway against experimental osteoarthritis.

Authors:  Sonia Nasi; Driss Ehirchiou; Athanasia Chatzianastasiou; Noriyuki Nagahara; Andreas Papapetropoulos; Jessica Bertrand; Giuseppe Cirino; Alexander So; Nathalie Busso
Journal:  Arthritis Res Ther       Date:  2020-03-17       Impact factor: 5.156

View more
  1 in total

1.  Xanthine Oxidoreductase-Mediated Superoxide Production Is Not Involved in the Age-Related Pathologies in Sod1-Deficient Mice.

Authors:  Shuichi Shibuya; Kenji Watanabe; Yusuke Ozawa; Takahiko Shimizu
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.